Observe Medical ASA (OSL:OBSRV)
Norway · Delayed Price · Currency is NOK 0.9740
-0.0260 (-2.60%)
At close: Aug 4, 2026
Observe Medical ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18.81 | 18.48 | 27.94 | 19.52 | 24.04 | |
Revenue Growth | 1.77% | -33.85% | 43.14% | -18.80% | 711.96% |
Cost of Revenue | 14.11 | 15.41 | 18.66 | 14.34 | 14.52 |
Gross Profit | 4.7 | 1.82 | 9.29 | 5.18 | 9.52 |
Selling, General & Admin | 15.29 | 16.14 | 25.96 | 28.52 | 19.01 |
Depreciation & Amortization Expenses | 13.32 | 14.38 | 14.16 | 10.93 | 3.46 |
Other Operating Expenses | 13.43 | 15.7 | 93.38 | 24.87 | 23.59 |
Total Operating Expenses | 42.04 | 46.22 | 133.5 | 64.32 | 46.06 |
Operating Income | -79.07 | -47.07 | -124.21 | -59.14 | -36.54 |
Interest Income | 44.16 | 5.68 | 7.52 | 19.12 | 15.71 |
Interest Expense | -13.73 | -17.33 | -18.4 | -10.7 | -5.49 |
Total Non-Operating Income (Expense) | 30.43 | -11.65 | -10.87 | 8.42 | 10.22 |
Pretax Income | -48.64 | -58.73 | -135.08 | -50.73 | -26.32 |
Provision for Income Taxes | 0 | 0 | 0.02 | 0.08 | 0 |
Net Income | -48.64 | -58.73 | -135.1 | -50.8 | -26.32 |
Net Income to Common | -48.64 | -58.73 | -135.1 | -50.8 | -26.32 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 67 | 15 | 3 | 3 | 1 |
Shares Outstanding (Diluted) | 67 | 15 | 3 | 3 | 1 |
Shares Change | 348.57% | 372.48% | - | 140.67% | 18.29% |
EPS (Basic) | -0.73 | -3.95 | -2.34 | -16.19 | -20.09 |
EPS (Diluted) | -0.73 | -3.95 | -2.34 | -16.19 | -20.09 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -25.97 | -29.27 | -32.47 | -56.26 | -27.01 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.39 | -1.97 | -10.32 | -17.88 | -20.66 |
Gross Margin | 24.99% | 9.85% | 33.24% | 26.52% | 39.59% |
Operating Margin | -420.31% | -254.67% | -444.52% | -302.97% | -152.00% |
Profit Margin | -258.57% | -317.72% | -483.50% | -260.24% | -109.48% |
FCF Margin | -138.07% | -158.37% | -116.21% | -288.21% | -112.35% |
EBITDA | -65.75 | -32.69 | -110.05 | -48.21 | -33.08 |
EBITDA Margin | -349.50% | -176.88% | -393.86% | -246.97% | -137.60% |
EBIT | -79.07 | -47.07 | -124.21 | -59.14 | -36.54 |
EBIT Margin | -420.31% | -254.67% | -444.52% | -302.97% | -152.00% |
Effective Tax Rate | 0.00% | 0.00% | -0.01% | -0.15% | 0.00% |